An experimental weight-loss drug from Eli Lilly & Co. helped patients lose weight with few side effects, according to the ...

A new study from the National Institutes of Health (NIH) has found that the incidence of 14 different cancer types increased ...

Agustin Lizarraga battles weight, diabetes to transform into a first-time boxer at the 20th Battle of the Badges. Discover his inspiring story of determination.

To help you decide which feline is the best fit for you, we spoke to expert vet Dr Rebecca MacMillan who helped us create ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Workplace productivity losses from loneliness-related health problems, absenteeism, and reduced engagement cost employers ...

Eli Lilly's (LLY) experimental obesity drug, eloralintide, shows up to 11% weight loss in 12 weeks with minimal side effects in early-stage trial. Read more here.

In a neighborhood facing food insecurity, the Food Literacy Center is planting the seeds for healthier futures—one recipe at a time.

Liver disease is a growing health concern in the United States, affecting millions of adults. One of the most common types is called nonalcoholic fatty liver disease (NAFLD). This condition happens ...

Whether you’re taking Ozempic for type 2 diabetes or for weight loss, you’re probably noticing a lot of changes in your body.

A new analysis of obesity guidelines suggests more evidence is needed to develop stronger guidelines for the transition ...

Eli Lilly's experimental obesity drug, eloralintide, helped some patients lose 11.5% of their body weight at 12 weeks in an ...